Skip to main content
ES
v1.2
Log in
N

Neuland Labs

NEULAND LABSNSE
₹20,360+0.00 (+0.00%)
Market Cap
₹25,284Cr.
P/E Ratio
50.8
P/B Ratio
13.94
EPS (TTM)
₹400.79
Div Yield
0.17%
ROCE
26.5%
ROE
21.2%
52W Low: ₹11,50052W High: ₹24,225
Themes:💊 Pharma & CDMO
Appears in 2 screens
🧱Consistent Performers
87
📉Oversold Rebound Watch
63
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 19.0% a year over three years.
  • Debt is 0.16× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Neuland_Labs — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5.8/ 10Overall
3/ 10Valuation
9/ 10Quality
4/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 50.8P/E: 50.8 | P/B: 13.94
Growth
GrowingSales CAGR — 3Y: 19% · 1Y: 78%
Profitability
High MarginROCE: 26.5% | ROE: 21.2%

Key Metrics

Valuation
PEG Ratio 1.69
Price / Sales 10.66x
Book Value ₹1461
Margins & returns
Operating Margin 32%
Net Margin 21.0%
Return on Assets 17.0%

Frequently Asked Questions

MarketsPortfolioChart